IMPORTANT INFORMATION
Due to legal restrictions, the information on this part of Lipum’s website is not accessible to
certain persons. We kindly ask you to review the following information and provide the
following confirmation each time you wish to access these webpages. Please note that the
terms set out below may be altered or updated and therefore it is important that you review
them each time you visit this page.
The information contained in this section of Lipum’s website is not intended for, and must not
be accessed by, or distributed or disseminated, directly or indirectly, in whole or in part, to
persons resident or physically present in the United States, Australia, Canada, Hong Kong,
Japan, New Zealand, Singapore, South Africa, or any other jurisdiction where such action is
wholly or partially subject to legal restrictions, or would require additional prospectuses,
registration or other measures than those required by Swedish law. The information on the
webpages does not constitute any offer regarding subscription rights, paid subscribed shares
or shares in Lipum (“Securities”) to any person in said jurisdictions. The information on the
webpages may not be forwarded or reproduced in such a manner that contravenes such
restrictions or gives cause to such requirements.
No Securities have been or will be registered under the United States Securities Act of 1933,
as amended (the “Securities Act”) or the securities legislation of any state or other
jurisdiction in the United States and thus the Securities may not be offered, subscribed for,
exercised, pledged, sold, resold, allotted, delivered or otherwise transferred, directly or
indirectly, in or into the United States. All offers and sales of securities in connection with
any rights issue in Lipum will be made outside of the United States and in reliance on, and in
compliance with, Regulation S under the Securities Act. There will be no public offering in the
United States.
No public offering of Securities is made to any country within the European Economic Area
(the “EEA”) other than Sweden. In other member states of the EEA, such offering may be
made only under an applicable exemption in the Prospectus Regulation (EU) 2017/1129 (the
“Prospectus Regulation”) and/or under any relevant implementation measure. What is said
above about other member states in the EEA than Sweden shall also apply to the United
Kingdom, where the Prospectus Regulation is part of domestic law under the European
Union (Withdrawal) Act 2018.
Lipum has made the assessment that the company conducts protection-worthy activities under
the Swedish foreign direct investment review Act (Sw. lagen (2023:560) om granskning av
utländska direktinvesteringar) (the “FDI Act”). This entails that investors that gain certain
influence in the company may need to notify investments in the company to, and obtain
approval from, the Swedish Inspectorate of Strategic Products (Sw. Inspektionen för
Strategiska Produkter) before such investments can be completed. Each shareholder should
consult an independent legal adviser on the possible application of the FDI Act in relation to
the rights issue for the individual shareholder.
To access the information contained in this section of Lipum’s website, all persons must first
ensure that they are not subject to legal restrictions that limit their right to access the
information.
We therefore kindly ask you to confirm that you are resident and physically present outside
the United States, Australia, Canada, Hong Kong, Japan, New Zealand, Singapore, South
Africa and any other jurisdiction where such action is wholly or partially subject to legal
restrictions, or would require additional prospectuses, registration or other measures than
those required by Swedish law, and are entitled to access the information on these
webpages without being subject to restrictions in any law or other regulations and without
any further action being required by Lipum. We also kindly ask you to confirm that you
have read the information, conditions and restrictions above, and confirm that you agree to
comply with these.
IMPORTANT INFORMATION
Due to legal restrictions, the information on this part of Lipum’s website is only directed at
and accessible to persons who are resident and physically present in Sweden and authorised
persons who are resident and physically present in other jurisdictions outside the United
States, Australia, Canada, Hong Kong, Japan, New Zealand, Singapore, South Africa, or any
other jurisdiction where such action is wholly or partially subject to legal restrictions, or
would require additional prospectuses, registration or other measures than those required by
Swedish law.
